The article I wrote on SeekingAlpha two and a half years
The article I wrote on SeekingAlpha two and a half years ago which everyone here is referring to as a "hit piece" was entirely factually correct, links and all, and told investors exactly what they needed to know. Had anyone actually listened to what I was saying rather than fighting me because the article didn't pump their stock, they could have sold at $1.40 at that time rather than holding until now with a current ask of $0.10.
You people should be thanking me for giving you the information and the opportunity--it's your own fault that you didn't listen. I understand there is always conflicting information out there but I laid out everything very clearly in my article.
I also completely understand that my posting here doesn't do any good. Shareholders have been absolutely hammered and another $0.10 isn't going to make much of a difference, except maybe for those who are hell-bent on averaging down. Mostly I'm just talking about the company. Maybe as some investors move on to their next investment, my posting will have given them some insight in how to avoid being scammed in the future with a too-good-to-be-true 'technology'. I understand that's not going to help very many of the people here who are posting believing FUD is the problem with their penny stock.
Plastic2Oil, Inc. (PTOI) Stock Research Links
Yes, I understand your penny stock also is the real deal, created with the inventiveness of Edison and destined to be the next Microsoft. Yes, I understand that the delays are also only because your company is making their product and/or technology even more revolutionary.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Breaking Ground with Innovative Obesity Treatment In the world of biotech, where breakthroughs are hard-fought and the stakes can seem insurmountable, Ascletis Pharma is swinging for the fences with their latest maneuver. They've submitted an Investigational New Drug application to the U.S. Food and Drug Administration for ASC30_39 FDC—a pioneering fixed-dose combo pill...
Continue Reading
CRET Broadens the Path to Fixed-Income Security If you're the type who gets a rash just thinking about stock market jitters, pay attention: Compound Real Estate Bonds (CREB) has cracked the door open a bit wider for your retirement peace of mind. They've teamed up with Equity Trust to offer their rock-solid 8.50% APY bonds through self-directed IRAs. That's right—these...
Continue Reading
Diving into Uncharted Waters HanAll F&B is setting its sights on the U.S. market, a move that could be make-or-break for this South Korean food manufacturer. With their recent rebranding from Taebaek Sanchae Naengmyeon Farming Association, they're not just changing names—they're shifting operational gears. The name might sound new, but the gutsy ambition behind it is as...
Continue Reading
Financial Gains and Strategic Shifts Oh, here we go again—another quarterly report from Hansa Biopharma, and this one’s got some meat on its bones. They’ve sparked up their financial engine with a hefty €115 million licensing deal with SERB, which is a real shot in the arm. As any investor worth their salt would see, this isn’t just about piling cash. It's...
Continue Reading
Oil Market Faces Uncertain Waves The energy sector's a rough sea these days, with Brent crude prices yo-yoing close to that $100 mark. If you're looking for clarity, don't hold your breath—the EIA's latest report suggests we’re sticking near this price for the foreseeable future before easing into more palatable waters come late 2027. But we ain't there yet, as U.S....
Continue Reading
Viatris Steps Into the Limelight Across Conferences Investors, listen up—Viatris Inc. is about to spill some beans at a trio of high-stakes healthcare gatherings. Set to rub elbows with the who's who of the biopharma world, this global healthcare crusader's on a mission. They're lining up to have face time at the UBS Global Biopharma Conference, the Jefferies Global...
Continue Reading
A Showdown in Beijing: Esports at Its Peak IEM Beijing 2026 wrapped up on November 8, lighting up the Bloomage Biotech•Biohyalux ECM Arena with some high-octane Counter-Strike 2 matches. In a region that's nothing short of a digital battleground, Team MOUZ clinched the crown. And yeah, they didn't just do it solo; they did it seated in style on AutoFull chairs, the...
Continue Reading
Modaxo Steps Up for UITP Summit Hamburg 2027 Well, Modaxo's back at it again, laying down roots in the public transport sector. Fresh off the press, they've announced they'll be a Platinum Partner for the UITP Summit in Hamburg 2027. That's not just a handshake for the cameras, folks. It's a clear shout-out about where they see themselves in this industry. Living Their...
Continue Reading
Reading Between the Financial Lines Nielsen's latest move throws a hefty $1.4 billion worth of senior secured notes into the market, aimed at scooping up DoubleVerify in a play that’s as daring as it is dicey. It's the kind of gamble you discuss with your coffee buddy, sipping something strong enough to wake the dead, and exactly the kind of deal that gets seasoned...
Continue Reading
Elevated Ambitions in Québec: PMET's Lithium-Tantalum Leap PMET Resources just handed us an intriguing update on their Shaakichiuwaanaan project up in Québec. They're reshaping the roadmap to crank out both lithium and tantalum more efficiently than a bear on a honeycomb. The revised feasibility study has put to paper numbers that have optimists—and skeptics...
Continue Reading
Top 5 Most Recently Viewed Articles
Google Reduces AI Service Costs for Federal Agencies Alphabet’s Google has announced a notable price reduction for its artificial intelligence (AI) and cloud services, specifically tailored for federal agencies. The new AI suite, named “Gemini for Government,” is being offered at an incredibly low cost of $0.47 per unit. This initiative reflects Google’s...
Continue Reading
Leadership in Legal Professionalism David Shiner, a dedicated attorney and Founding Partner of Shiner Law Group, P.A., has taken a significant step in his legal career by being appointed as Chair of the South Palm Beach County Bar Association's Professionalism Committee for the upcoming term. This prestigious appointment underscores his commitment to enhancing...
Continue Reading
Class Action Lawsuit Against F5, Inc. F5, Inc. is currently involved in a class action lawsuit following a data breach that significantly impacted the company. The legal proceedings have emerged due to allegations that the company failed to disclose crucial information concerning its financial health during a specific period. Key Details of the Allegations The lawsuit...
Continue Reading
Tesla Inc. Challenges $243 Million Damages Verdict Attorneys for Tesla Inc. (NASDAQ: TSLA) are contesting a recent judgment from a Miami Federal court, which ordered the company to pay over $243 million in damages related to a fatal crash involving a Florida woman in 2019. The court's decision has sparked significant backlash from Tesla's legal team, who argue that the...
Continue Reading
Projected Growth of the Software Market According to Precedence Research, the global software market is set to expand from USD 659.17 billion in 2023 to around USD 2,248.33 billion by 2034. This remarkable growth is mainly fueled by advancements in technology, supportive government initiatives, and a rise in research projects. Key Insights on the Software Market Several...
Continue Reading